FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

A stage 4 prostate cancer survivor shares his story of positivity and gratitude. After doing some yard landscaping, I began to have some rather severe back pain and muscle spasms. My first thought was ...

So for the listeners out there, maybe they're seeing some prostate cancer, they're seeing a lot, they're trying to think about factors to look for and who those patients we should be looking for. Is ...

Recognising these subtle body changes can lead to an earlier diagnosis, when treatment is more likely to be successful ...

A group of doctors who specialize in cancer have detailed four subtle symptoms of the disease that people often overlook. The American Cancer Society predicts 2.1 million people in the US will be ...

PYLARIFY TruVu™ (piflufolastat F 18) injection (also known as 18F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and ...

Researchers at King's College London have discovered that an immune protein best known for protecting the body against ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

Merve Ceylan is a dietitian and health writer with four years of experience writing for companies in the nutrition and health industry. Some foods and drinks can worsen prostate health. Saturated fats ...

The Town of Pearisburg is coming together to help a local man who has served them for decades. Timmy Ratcliffe, a member of the town’s volunteer fire department for 33 ...

I met with an oncologist on Nov 16, 2020. He said I had an aggressive form of prostate cancer that had metastasized throughout the bones in my pelvic region, putting me at state four in cancer’s ...